Improving the quality of clinical care for patients with osteoporosis

References

• Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA. Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J. Gen. Intern. Med.18(1), 17–22 (2003).
   PubMed Web of Science ®Google Scholar
• Sambrook P, Cooper C. Osteoporosis. Lancet367, 2010–2018 (2006).
   PubMed Web of Science ®Google Scholar
• Who are candidates for prevention and treatment for osteoporosis? Osteoporos. Int.7(1), 1–6 (1997).
   Web of Science ®Google Scholar
• Kanis JA, Borgstrom F, De Laet C et al. Assessment of fracture risk. Osteoporos. Int.16(6), 581–589 (2005).
   PubMed Web of Science ®Google Scholar
• Miller RG. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture. Geriatrics61(1), 24–30 (2006).
   Google Scholar
• Andrade SE, Majumdar SR, Chan KA et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch. Intern. Med.163(17), 2052–2057 (2003).
   PubMed Web of Science ®Google Scholar
• Bellantonio S, Fortinsky R, Prestwood K. How well are community-living women treated for osteoporosis after hip fracture? J. Am. Geriatr. Soc.49(9), 1197–1204 (2001).
   Google Scholar
• Briancon D, de Gaudemar JB, Forestier R. Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices. Joint Bone Spine71(2), 128–130 (2004).
   Google Scholar
• Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos. Int.15(10), 767–778 (2004).
   PubMed Web of Science ®Google Scholar
• Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch. Intern. Med.163(18), 2165–2172 (2003).
   PubMed Web of Science ®Google Scholar
• Follin SL, Black JN, McDermott MT. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy23(2), 190–198 (2003).
   Google Scholar
• Gunter MJ, Beaton SJ, Brenneman SK, Chen YT, Abbott TA 3rd, Gleeson JM. Management of osteoporosis in women aged 50 and older with osteoporosis-related fractures in a managed care population. Dis. Manag.6(2), 83–91 (2003).
   Google Scholar
• Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am. J. Med.109(4), 326–328 (2000).
   PubMed Web of Science ®Google Scholar
• Panneman MJ, Lips P, Sen SS, Herings RM. Undertreatment with antiosteoporotic drugs after hospitalization for fracture. Osteoporos. Int.15(2), 120–124 (2004).
   PubMed Web of Science ®Google Scholar
• Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir. Med. J.93(4), 105–107 (2000).
   Google Scholar
• Raisz LG. Clinical practice. Screening for osteoporosis. N. Engl. J. Med.353(2), 164–171 (2005).
   PubMed Web of Science ®Google Scholar
• Solomon DH, Morris C, Cheng H et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin. Proc.80(2), 194–202 (2005).
   PubMed Web of Science ®Google Scholar
• Solomon DH, Brookhart MA, Gandhi TK et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am. J. Med.117(12), 919–924 (2004).
   PubMed Web of Science ®Google Scholar
• Sloane PD, Gruber-Baldini AL, Zimmerman S et al. Medication undertreatment in assisted living settings. Arch. Intern. Med.11 164(18), 2031–2037 (2004).
   Google Scholar
• Gudbjornsson B, Juliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann. Rheum. Dis.61(1), 32–36 (2002).
   PubMed Web of Science ®Google Scholar
• Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum.46(12), 3136–3142 (2002).
   PubMed Web of Science ®Google Scholar
• Ettinger B, Chidambaran P, Pressman A. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am. J. Manag. Care7(6), 597–605 (2001).
   PubMed Web of Science ®Google Scholar
• Mudano A, Allison J, Hill J, Rothermel T, Saag K. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J. Rheumatol.28(6), 1298–1305 (2001).
   PubMed Web of Science ®Google Scholar
• Smith MD, Cheah SP, Taylor K, Ahern MJ. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. J. Rheumatol.28(3), 566–570 (2001).
   Google Scholar
• Yood RA, Harrold LR, Fish L et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch. Intern. Med.161(10), 1322–1327 (2001).
   PubMed Web of Science ®Google Scholar
• Curtis JR, Westfall AO, Allison JJ et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum.52(8), 2485–2494 (2005).
   PubMed Web of Science ®Google Scholar
• Soucy E, Bellamy N, Adachi JD et al. A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists. J. Rheumatol.27(6), 1506–1512 (2000).
   Google Scholar
• Tanvetyanon T. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer103(2), 237–241 (2005).
   PubMed Web of Science ®Google Scholar
• Walker-Bone K, Wood A, Hull R et al. The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice. Clin. Med.4(5), 431–436 (2004).
   Google Scholar
• Morris CA, Cabral D, Cheng H et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J. Gen. Intern. Med.19(7), 783–790 (2004).
   PubMed Web of Science ®Google Scholar
• Solomon DH, Avorn J, Katz JN et al. Compliance with osteoporosis medications. Arch. Intern. Med.165(20), 2414–2419 (2005).
   PubMed Web of Science ®Google Scholar
• McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas.48(3), 271–287 (2004).
   PubMed Web of Science ®Google Scholar
• Curtis J, Westfall A, Allison J, Freeman A, Saag K. Channeling and Persistence with Alendronate and Risedronate among Chronic Glucocorticoid Users. Osteoporos. Int.17(8), 1268–1274 (2006).
   Google Scholar
• Segal E, Tamir A, Ish-Shalom S. Compliance of osteoporotic patients with different treatment regimens. Isr. Med. Assoc. J.5(12), 859–862 (2003).
   PubMedGoogle Scholar
• Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr. Med. Res. Opin.21(9), 1453–1460 (2005).
   PubMed Web of Science ®Google Scholar
• Tosteson AN, Grove MR, Hammond CS et al. Early discontinuation of treatment for osteoporosis. Am. J. Med.115(3), 209–216 (2003).
   PubMed Web of Science ®Google Scholar
• Yood RA, Emani S, Reed JI, Lewis BE, Charpentier M, Lydick E. Compliance with pharmacologic therapy for osteoporosis. Osteoporos. Int.14(12), 965–968 (2003).
   PubMed Web of Science ®Google Scholar
• Siris E, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. Adherence to bisphosphonate therapy: relationship to bone fractures at 24 months in women with post-menopausal osteoporosis. Presented at: the National Osteoporosis Foundation 6th International Symposium on Osteoporosis; April 6–9, Washington DC, USA 2005.
   Google Scholar
• Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos. Int.15(12), 1003–1008 (2004).
   PubMed Web of Science ®Google Scholar
• Emkey RD, Ettinger M. Improving compliance and persistence with bisphosphonate therapy for osteoporosis. Am. J. Med.119(4 Suppl. 1), S18–S24 (2006).
   Web of Science ®Google Scholar
• Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA282(15), 1458–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Pazirandeh M. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? J. Contin. Educ. Health Prof.22(3), 142–151 (2002).
   PubMedGoogle Scholar
• Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: current evidence and future implications. J. Contin. Educ. Health Prof.24(Suppl. 1), S31–S37 (2004).
   Google Scholar
• Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int. J. Technol. Assess. Health Care21(3), 380–385 (2005).
   PubMed Web of Science ®Google Scholar
• Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA6 274(9), 700–705 (1995).
   Google Scholar
• Calvo CB, Rubinstein A. Influence of new evidence on prescription patterns. J. Am. Board Fam. Pract.15(6), 457–462 (2002).
   PubMedGoogle Scholar
• Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J. Bone Joint Surg. Am.A84(8), 1342–1348 (2002).
   Google Scholar
• Centor R, Casebeer L, Klapow J. Using a combined CME course to improve physicians’ skills in eliciting patient adherence. Acad. Med.73(5), 609–610 (1998).
   Google Scholar
• Tierney WM, Overhage JM, McDonald CJ. Computerizing guidelines: factors for success. Proc. AMIA Annu. Fall Symp.459–462 (1996).
   Google Scholar
• Thomson O’Brien MA, Freemantle N, Oxman AD, Wolf F, Davis DA, Herrin J. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev.2, CD003030 (2001).
   Google Scholar
• Thomson O’Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev.2, CD000125 (2000).
   Google Scholar
• Thomson O’Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev.2, CD000260 (2000).
   Google Scholar
• Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol. Assess.8(6), 1–72 (2004).
   Web of Science ®Google Scholar
• Johnston ME, Langton KB, Haynes RB, Mathieu A. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann. Intern. Med.120(2), 135–142 (1994).
   PubMed Web of Science ®Google Scholar
• Thomson O’Brien MA, Oxman AD et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev.2, CD000409 (2000).
   Google Scholar
• McCormack JP, Dolovich L, Levine M et al. Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use? Health Expect.6(4), 281–289 (2003).
   Google Scholar
• Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J. Rheumatol.31(3), 550–556 (2004).
   Google Scholar
• Lata PF, Binkley NC, Elliott ME. Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause9(6), 449–455 (2002).
   Google Scholar
• Evers-Kiebooms G, van den Berghe H. Impact of genetic counseling: a review of published follow-up studies. Clin. Genet.15(6), 465–474 (1979).
   PubMed Web of Science ®Google Scholar
• Davis P, Kvern B, Donen N, Andrews E, Nixon O. Evaluation of a problem-based learning workshop using pre- and post-test objective structured clinical examinations and standardized patients. J. Contin. Educ. Health Prof.20(3), 164–170 (2000).
   PubMedGoogle Scholar
• Liberman UA, Weiss SR, Broll J et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N. Engl. J. Med.333(22), 1437–1443 (1995).
   PubMed Web of Science ®Google Scholar
• Ashe M, Khan K, Guy P et al. Wristwatch-distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. J. Hand Ther.17(3), 324–328 (2004).
   Google Scholar
• Thornton H, Edwards A, Elwyn G. Evolving the multiple roles of ‘patients’ in health-care research: reflections after involvement in a trial of shared decision-making. Health Expect.6(3), 189–197 (2003).
   Google Scholar
• Delmas PD, Adami S, Strugala C et al. Intravenous Ibandronate injections in postmenopausal women with osteoporosis. Arthritis Rheum.54(6), 1838–1846 (2006).
   PubMed Web of Science ®Google Scholar
• Reid IR, Brown JP, Burckhardt P et al. Intravenous Zoledronic acid in postmenopausal women with low bone density. N. Engl. J. Med.346(9) 653–661 (2002).
   PubMed Web of Science ®Google Scholar